Publications by authors named "David M Flavell"

Claim this Profile
I
IP receptor-dependent activation of PPARgamma by stable prostacyclin analogues.
Emilia Falcetti, David M Flavell, Bart Staels, Andrew Tinker, Sheila G Haworth

Biochem Biophys Res Commun· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The lipoprotein lipase gene serine 447 stop variant influences hypertension-induced left ventricular hypertrophy and risk of coronary heart disease.
Philippa J Talmud, David M Flavell, Khaled Alfakih, Jackie A Cooper, Anthony J Balmforth

Clin Sci (Lond)· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipoprotein-associated phospholipase A2 A379V variant is associated with body composition changes in response to exercise training.
Peter T E Wootton, David M Flavell, Hugh E Montgomery, Mike World, Steve E Humphries

Nutr Metab Cardiovasc Dis· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PPARalpha gene variation and physical performance in Russian athletes.
Ildus I Ahmetov, Irina A Mozhayskaya, David M Flavell, Irina V Astratenkova, Antonina I Komkova

Eur J Appl Physiol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variation in the lipoprotein lipase gene influences exercise-induced left ventricular growth.
David M Flavell, Peter T E Wootton, Saul G Myerson, Michael J World, Dudley J Pennell

J Mol Med (Berl)· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peroxisome proliferator-activated receptor alpha gene variation influences age of onset and progression of type 2 diabetes.
David M Flavell, Helen Ireland, Jeffrey W Stephens, Emma Hawe, Jay Acharya

Diabetes· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to micronized fenofibrate treatment is associated with the peroxisome-proliferator-activated receptors alpha G/C intron7 polymorphism in subjects with type 2 diabetes.
Christelle Foucher, Stephanie Rattier, David M Flavell, Philippa J Talmud, Steve E Humphries

Pharmacogenetics· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variation in USF1 shows haplotype effects, gene : gene and gene : environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II.
Wendy Putt, Jutta Palmen, Viviane Nicaud, David-Alexandre Tregouet, Nadia Tahri-Daizadeh, David M Flavell

Hum Mol Genet· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transgenesis and neuroendocrine physiology: a transgenic rat model expressing growth hormone in vasopressin neurones.
Sara E Wells, David M Flavell, Gordon W Bisset, Pamela A Houston, Helen Christian

J Physiol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel functional polymorphism in the PECAM-1 gene (53G>A) is associated with progression of atherosclerosis in the LOCAT and REGRESS studies.
Mohamed A Elrayess, Karen E Webb, David M Flavell, Mikko Syvänne, Marja-Riitta Taskinen

Atherosclerosis· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression of atherosclerosis is associated with variation in the alpha1-antitrypsin gene.
Philippa J Talmud, Steve Martin, George Steiner, David M Flavell, David B Whitehouse

Arterioscler Thromb Vasc Biol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of the PPARA locus on chromosome 22q13.3 as a modifier gene in familial combined hyperlipidemia.
Petra M H Eurlings, Carla J H van der Kallen, Jan M W Geurts, David M Flavell, Tjerk W A de Bruin

Mol Genet Metab· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haplotype analysis of the PPARgamma Pro12Ala and C1431T variants reveals opposing associations with body weight.
Alex Doney, Bettina Fischer, David Frew, Alastair Cumming, David M Flavell

BMC Genet· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the human PPARalpha promoter: identification of a functional nuclear receptor response element.
Inés Pineda Torra, Yalda Jamshidi, David M Flavell, Jean-Charles Fruchart, Bart Staels

Mol Endocrinol· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peroxisome proliferator-activated receptor alpha gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease.
David M Flavell, Yalda Jamshidi, Emma Hawe, Inés Pineda Torra, Marja-Riitta Taskinen

Circulation· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peroxisome proliferator--activated receptor alpha gene regulates left ventricular growth in response to exercise and hypertension.
Yalda Jamshidi, Hugh E Montgomery, Hans-Werner Hense, Saul G Myerson, Ines Pineda Torra, David M Flavell

Circulation· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis